NM_004415.4:c.3133C>T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004415.4(DSP):c.3133C>T(p.Arg1045*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000342 in 1,461,860 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004415.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- arrhythmogenic right ventricular dysplasia 8Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- keratosis palmoplantaris striata 2Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Ambry Genetics, Genomics England PanelApp
- skin fragility-woolly hair-palmoplantar keratoderma syndromeInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, G2P, Genomics England PanelApp, Ambry Genetics
- arrhythmogenic cardiomyopathy with wooly hair and keratodermaInheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, ClinGen, Orphanet, Ambry Genetics
- cardiomyopathy, dilated, with wooly hair, keratoderma, and tooth agenesisInheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
- lethal acantholytic epidermolysis bullosaInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- striate palmoplantar keratodermaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- severe dermatitis-multiple allergies-metabolic wasting syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004415.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DSP | NM_004415.4 | MANE Select | c.3133C>T | p.Arg1045* | stop_gained | Exon 23 of 24 | NP_004406.2 | ||
| DSP | NM_001319034.2 | c.3133C>T | p.Arg1045* | stop_gained | Exon 23 of 24 | NP_001305963.1 | |||
| DSP | NM_001008844.3 | c.3133C>T | p.Arg1045* | stop_gained | Exon 23 of 24 | NP_001008844.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| DSP | ENST00000379802.8 | TSL:1 MANE Select | c.3133C>T | p.Arg1045* | stop_gained | Exon 23 of 24 | ENSP00000369129.3 | ||
| DSP | ENST00000418664.3 | TSL:1 | c.3133C>T | p.Arg1045* | stop_gained | Exon 23 of 24 | ENSP00000396591.2 | ||
| DSP | ENST00000713904.1 | c.3007C>T | p.Arg1003* | stop_gained | Exon 23 of 24 | ENSP00000519203.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461860Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727224 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Primary dilated cardiomyopathy;C0349788:Arrhythmogenic right ventricular cardiomyopathy Pathogenic:1
The p.Arg1045X variant in DSP has not been previously reported in individuals wi th cardiomyopathy or in large population studies. This nonsense variant leads to a premature termination codon at position 1045, which is predicted to lead to a truncated or absent protein. Heterozygous loss of function of the DSP gene is a n established disease mechanism in individuals with arrhythmogenic right ventric ular cardiomyopathy, and has recently been associated with dilated cardiomyopath y. In summary, although additional studies are required to fully establish its c linical significance, the p.Arg1045X variant is likely pathogenic.
Arrhythmogenic right ventricular dysplasia 8;C1854063:Arrhythmogenic cardiomyopathy with wooly hair and keratoderma Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg1045*) in the DSP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DSP are known to be pathogenic (PMID: 20716751, 24503780, 25227139). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy (PMID: 27532257, 28527814). ClinVar contains an entry for this variant (Variation ID: 464961). For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:1
PVS1, PM2_supporting; PS4_moderate
Primary dilated cardiomyopathy Pathogenic:1
Cardiovascular phenotype Pathogenic:1
The p.R1045* pathogenic mutation (also known as c.3133C>T), located in coding exon 23 of the DSP gene, results from a C to T substitution at nucleotide position 3133. This changes the amino acid from an arginine to a stop codon within coding exon 23. This alteration has been reported in one individual from a dilated cardiomyopathy (DCM) genetic testing cohort and in one individual with arrhythmogenic right ventricular cardiomyopathy (ARVC) (Walsh R et al. Genet. Med., 2017 02;19:192-203; Castelletti S et al. Int. J. Cardiol., 2017 Dec;249:268-273). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Alterations in DSP that result in haploinsufficiency or protein truncation have been reported in patients with ARVC and DCM (Fressart V et al. Europace. 2010;12(6):861-8; Elliott P et al. Circ Cardiovasc Genet. 2010;3(4):314-22; Quarta G et al. Circulation. 2011;123(23):2701-9; Garcia-Pavia P et al. Heart. 2011;97(21):1744-52; Rasmussen TB et al. Clin Genet. 2013;84(1):20-30; Pugh TJ et al. Genet Med. 2014;16(8):601-8). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Cardiac arrhythmia Pathogenic:1
Variant summary: DSP c.3133C>T (p.Arg1045X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. A truncation downstream of this position has been classified as pathogenic by our laboratory (c.3337C>T, p.Arg1113X). The variant was absent in 250892 control chromosomes (gnomAD). The variant, c.3133C>T, has been reported in the literature in individuals affected with dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy (Walsh_2017, Castelletti_2017). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 27532257, 28527814). Five submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic or likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at